2022 American Transplant Congress » Lung Transplantation

7:00pm-8:00pm

A Novel National Program to Maximize Utilization of Lung and Heart Allografts from Donors After Brain Death (DBD) and Donors After Circulatory Death (DCD) for Transplantation

W. Hassanein, N. Dang, A. Hassanein, S. Brann, S. LaFrancesca, S. Reddy, M. Al Salihi, T. Khayal

7:00pm-8:00pm

Alemtuzumab and Basilximab Induction Therapy in Lung Transplantation

M. Furukawa, E. Chan, P. G. Sanchez

7:00pm-8:00pm

Assessment of Letermovir as Universal Prophylaxis for Cytomegalovirus Infection in Lung Transplant Recipients

L. F. Borges, T. Sparkman, K. Gutierrez, J. Banbury

7:00pm-8:00pm

Association of Chest CT Score During Acute COVID-19 Illness with Subsequent Lung Function Loss Among Lung Transplant Patients

Q. M. Halverson, K. Batra, L. D. Mahan, M. Mohanka, A. C. Lawrence, J. Joerns, S. Bollineni, V. Kaza, I. L. Timofte, C. D. Kershaw, L. C. Terada, F. Torres, A. Banga

7:00pm-8:00pm

Clinical Impact of a Modified Lung Allocation Score That Mitigates Selection Bias

E. M. Schnellinger¹, E. Cantu², D. E. Schaubel¹, S. E. Kimmel³, A. J. Stephens-Shields¹

7:00pm-8:00pm

Data-Driven Clustering Distinguishes Infection from Rejection During Hospital Admissions Following Pediatric Lung Transplantation

C. D. Britto¹, D. Boyer², G. Visner³, G. Priebe⁴, L. Midyat³

7:00pm-8:00pm

Direct Central Ambulatory Venoarterial Extracorporeal Membrane Oxygenation and Double Lung Transplantation without Graft Reduction with Extreme Mediastinal Shift

A. Gorton¹, S. Keshavamurthy²

7:00pm-8:00pm

Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior?

C. Hoopes

7:00pm-8:00pm

Effects of Pre-Lung Transplantation Pulmonary Rehabilitation on Functional Capacity and Quality of Life

R. M. AlGhofaily

7:00pm-8:00pm

Emphysematous Cystitis in a Lung Transplant Recipient with BK Viremia

D. Razia, J. Klein, H. Mohamed, A. Arjuna

7:00pm-8:00pm

Evaluation of Voriconazole Dosing for Preventing Aspergillus in Lung Transplant Recipients

A. Chaplain¹, B. J. Pierce¹, C. Pham¹, A. Hutchins¹, W. L. Musick¹, D. T. Nguyen², E. A. Graviss², S. W. Yau³, J. G. Youssef³, A. Goodarzi³, H. J. Huang³

7:00pm-8:00pm

Immunomodulation in Lung Transplant May Facilitate Transformation of Usual Interstitial Pneumonia Into Pleuroparenchymal Fibroelastosis

Q. Cai¹, K. Batra², J. R. Torrealba¹

7:00pm-8:00pm

Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection

L. Zaffiri, R. Hallak, S. Leonard, M. Neely, A. Hulber, H. Berry, K. A. Young, J. M. Reynolds

7:00pm-8:00pm

Impact of Mycetoma in Lung Transplant Recipients

A. Majeed, S. Singh, J. Lum

7:00pm-8:00pm

Impact of Respiratory Viral Panel Testing on Clinical Decision-Making Among Lung Transplant Recipients Based on Extent of Immunosuppression

A. C. Vostal¹, A. Lynen², S. Chintalapati¹, M. Uehling¹, K. Prakash², A. Shishido¹, J. Baghdadi²

7:00pm-8:00pm

Incidence and Laterality of Pulmonary Emboli in Single Lung Transplant Recipients

F. Pyarali¹, J. Thomas², A. Peiris², R. Rampolla¹

7:00pm-8:00pm

Local Intragraft Humoral Immune Response in Chronic Lung Allograft Dysfunction

E. Miyamoto¹, S. C. Juvet², D. Vosoughi², J. Wang², J. Al-Refaee², T. Daigneault², A. Duong², S. Moshkelgosha², S. Keshavjee², K. Tinckam², A. Chruscinski³, D. Hwang⁴, T. Martinu²

7:00pm-8:00pm

Lung Transplant Waitlist Outcomes for Blood Group O Candidates After the Expansion of the Primary Allocation Unit in November 2017

S. Greissman¹, M. Anderson², S. Arcasoy³, A. Dimango³, M. Gabriela³, H. Grewal³, H. Robbins³, L. Shah³, J. Costa³, F. D'Ovidio³, M. Leiva Juarez³, P. Lemaitre³, J. Sonett³, L. Benvenuto³

7:00pm-8:00pm

Lung Transplantation For Covid-19: An International Registry

M. G. Ison¹, R. Giris², O. Dias³, R. Vos⁴, J. Magnusson⁵, T. Zangeneh⁶, E. D. Lease⁷, S. Aslam⁸, M. Weder⁹

7:00pm-8:00pm

Missed Opportunities in Lung Transplant

C. J. Lehr, P. R. Gunsalus, M. Valapour, J. E. Dalton

7:00pm-8:00pm

Oseltamivir for the Prevention of Influenza Infection in Lung Transplant Recipients at an Academic Medical Center

D. Majmundar, A. Mishkin, J. Burnell, C. Ruggia-Check, J. Au

7:00pm-8:00pm

Outcomes in Lung Transplant Recipients Switched from Tacrolimus to Cyclosporine Due to Hyperammonemia Early Post-Transplantation

S. Goyal, J. Lyons, P. Stracener, B. Bemiss

7:00pm-8:00pm

Patient Outcomes After Heart and Double Lung Transplant from a Single High-Volume Center

R. P. Brumer¹, A. Goodarzi², R. Chihara¹

7:00pm-8:00pm

Perioperative Cardiovascular Outcomes of Pre-Transplant ECMO in Recipients of Lung Transplant

F. Anjum¹, R. Munshi², A. M. Courtwright¹, M. M. Crespo¹, J. C. Salgado¹, J. D. Christie¹, V. N. Ahya¹, N. Patel¹, D. Hadjiliadis¹, E. Clausen¹, M. Cevasco³, E. E. Cantu³, C. A. Bermudez³, J. M. Diamond¹

7:00pm-8:00pm

Pooled Prevalence of Pulmonary Embolism in Lung Transplant Recipients – A Meta-Analysis

F. Pyarali, A. Stevens, R. Rampolla

7:00pm-8:00pm

Risk Factors for Extubation Failure Post- Lung Transplantation

A. J. Trindade¹, W. D. Gannon¹, A. G. Dragnich¹, G. Dahlberg¹, C. T. Demarest², E. S. Lambright², K. A. McPherson¹, S. G. Norfolk¹, C. M. Shaver¹, I. M. Robbins¹, M. Bacchetta²

7:00pm-8:00pm

Simultaneous Lung and Kidney Transplant in a Young Patient with COVID-19

M. Bitar¹, J. G. Youssef², S. Yau², A. Goodarzi², G. Youssef³

7:00pm-8:00pm

Single Center Retrospective Study Examining the Incidence of Chronic Kidney Disease After Lung Transplantation and Its Associated Risk Factors

S. Kapoor¹, Y. Azzi¹, M. Ajaimy¹, P. Loarte-Campos¹, C. Pynadath¹, A. Mansour¹, E. Akalin², L. Liriano-Ward¹

7:00pm-8:00pm

Spectrum of Pre-Transplant Esophagram Abnormalities and Association with Long-Term Outcomes

I. Lill¹, D. Lovin², A. C. Lawrence², M. Mohanka², J. Joerns², S. Bollineni², I. L. Timofte², V. Kaza², M. Wait³, F. Torres², A. Banga²

7:00pm-8:00pm

Temporal Trends in Utilization, Discard, and Outcomes for Extended Criteria Donor Lungs

A. Hallett¹, L. Zeiser¹, W. Lightle², J. Ruck¹, J. Alejo¹, A. Massie¹, D. Segev¹

7:00pm-8:00pm

Textbook Outcome in Lung Transplantation: Planned VA ECMO versus Off-Pump

S. E. Halpern¹, M. C. Wright², G. Madsen², B. Chow², J. C. Haney³, J. A. Klapper³, B. A. Bottiger², M. G. Hartwig³

7:00pm-8:00pm

The Addition of Bortezomib to a Rituximab Based Antibody Mediated Rejection Treatment Protocol in Lung Transplant

M. Galle, P. Stracener, K. Warrior, J. Lyons

7:00pm-8:00pm

The Impact of Long-Term Exposure to Tacrolimus on Chronic Kidney Disease Following Lung Transplantation: A Retrospective Analysis from a Single Transplantation Center

D. Xiong, J. Zhang, J. Chen

7:00pm-8:00pm

The Unique Course of dd-cfDNA After Lung Transplant

D. Levine¹, C. Giner¹, C. Pham², R. Woodward³, A. Roux⁴

7:00pm-8:00pm

Therapeutic Drug Monitoring of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Patients

S. Sial, K. Cunningham, J. Moore, C. Dagostino, K. Lang, C. Kane

7:00pm-8:00pm

Utility of Bronchoalveolar Lavage Cytology for Detection of Malignancy or Infection in Lung Transplant Recipients

G. Cerro Chiang¹, R. Rampolla²

7:00pm-8:00pm

Utility of Cytomegalovirus T-Cell Immunity Panel to Predict CMV Infections in Lung Transplant Recipients

R. W. Lincoln¹, B. J. Pierce¹, C. Pham¹, S. W. Yau², A. Goodarzi², J. G. Youssef², H. J. Huang²

7:00pm-8:00pm

Variability In Plasma Donor-derived Cell-free DNA Levels With CLAD More Than 5-years After Lung Transplantation: Pilot Data

D. Levine¹, D. Ross²

7:00pm-8:00pm

dd-cfDNA Varies Among Diagnostics Groups of Pulmonary AMR

D. Levine¹, C. Giner¹, C. Pham², R. Woodward³, A. Roux⁴